Rob Neville (Springbok Ventures), Jean Anne Booth (Unaliwear), Carole Spangler Vaughn (Eisana), and Sheila Babnis (Insights and Impacts)
October 26, 2022 (SDP Invited Talk)
Abstract: This session will encompass discussions of the risks and opportunities involved in early-stage pharmaceutical development from the founder, VC, and drug development expert point of view. It will also showcase approaches and examples for management of these risks and the return on investment.
Click on the file below to hear a sample of the presentation.
Click here for access to the full video.
SDP membership is required for access to this webinar.
Keywords: framing framestruc, analysis and modeling anamod, adoption of da adoptda